VAC4EU Logo

Pfizer/BioNTech Comirnaty® myocarditis and pericarditis study

COVID-19 MAH-funded study Safety Comirnaty®
Back to studies

Ongoing study

The aim of this study is to characterise the clinical course of myocarditis and/or pericarditis diagnosed after receiving the Pfizer-BioNTech COVID-19 vaccine

Lead Scientific Center
University Medical Center Utrecht
Lead Operating Centre
Fondazione Penta
Programming Expertise
RTI Health Solutions
University Medical Center Utrecht
Statistical Expertise
RTI Health Solutions
University Medical Center Utrecht
Data Expert & Access Partners
Aragon Health Sciences Institute (IACS)
Drug Safety Research Unit (DSRU)
Fondazione Penta
Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
PHARMO Data Network
Società Italiana dei Medici di Medicina Generale e delle Cure Primarie (SIMG)
University of Oslo
Other Expertise
MediCom Consult
Teamit Institute
CPRD
EpiChron
HealthSearch
PEDIANET
PHARMO
SIDIAP
Poster presentation
A Systematic Review to Summarize and Critically Appraise of Existing Phenotype Libraries Using Electronic Health Records- a FLOW study under the VAC4EU organisation A Systematic Review to Summarize and Critically Appraise of Existing Phenotype Libraries Using Electronic Health Records- a FLOW study under the VAC4EU organisation

A Systematic Review to Summarize and Critically Appraise of Existing Phenotype Libraries Using Electronic Health Records- a FLOW study under the VAC4EU organisation

Sima Mohammadi, Cori Campbell, Sima Mohammadi... ICPE 2024
2024-08-28 View